Clinical Trial Update: A Drug-Drug Interaction Study to Evaluate Drug Transporter Interactions [Phase 1]

View source ↗

Summary

A Phase 1 drug-drug interaction study evaluating transporter interactions completed for a BioCryst-sponsored compound being developed for hereditary angioedema.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Angioedema

Snippet

Sponsor: BioCryst Pharmaceuticals | Conditions: Hereditary Angioedema | Phase 1 | Status: COMPLETED